Dr Goldhaber reviews the results of the CATCH trial on anticoagulation in cancer patients with venous thromboembolism.

Dr Frank Cetta sits down with Dr Michael Ackerman to talk about the challenges in using postmortem genetic testing to determine the cause of unexplained sudden death.

Unpublished trials, new CMS rules, statins after cardiac surgery, sudden death in the young, macrolide antibiotics, and FDA Commissioner Dr Robert Califf are discussed this week.

Carotid stenting vs surgery, leadless pacing, the CMS decision on Watchman, pioglitazone after stroke, and subretinal bleeding with antithrombins are discussed by Dr John Mandrola this week.

VA vs Non-VA medical care, flutter ablation in the real world, remote monitoring in heart failure, coffee and ectopy, and influenza and AF are discussed by Dr John Mandrola in this week’s podcast.

Interviewee Dr John Simpson failed as a bank teller after losing Jack Nicklaus's US Open winnings but went on to invent the first over-the-balloon catheter and other interventional cardiology devices.

Dr Thomas Allison sits down with Dr Francisco Lopez-Jimenez and Dr Steven Kopecky to talk about the use of LDL-C goals, and their approach to cholesterol management following the IMPROVE-IT trial.

Controversies over the ROCKET AF trial and Robert Califf's nomination for FDA commissioner, the treatment of ACS, and blood glucose control after cardiac surgery are discussed in this week's podcast.

Dr Goldhaber reviews a meta-analysis he coauthored of RE-COVER trial data suggesting that new oral anticoagulants may be a better option than warfarin for treating acute VTE.

A draft proposal for data sharing, women and AF, an ICD lead recall, vasovagal syncope, and prediabetes are discussed by Dr John Mandrola in this week's podcast.